End-of-day quote
Other stock markets
|
||
- EUR | - |
Chart calendar MediGene AG
Upcoming events on MediGene AG
Past events on MediGene AG
2024-06-24 05:00 | Annual General Meeting |
2024-05-21 09:00 | Benchmark Healthcare House Virtual Conference |
2024-05-15 09:00 | CIMT Meeting - Abstract Number 3 |
2024-05-15 09:00 | Association for Cancer Immunotherapy Meeting - Abstract Number: 3 |
2024-05-01 06:00 | Neoantigen International Summit |
2024-04-26 03:00 | Q1 2024 Earnings Release |
2024-04-25 08:15 | Europe CHI Immuno- Oncology Summit |
2024-04-23 | Rights Issue: 1 new share @ 1.2 EUR for 5 existing shares |
2024-04-07 16:30 | American Association for Cancer Research Meeting |
2024-03-28 10:00 | Q4 2023 Earnings Call |
2024-03-28 02:30 | Q4 2023 Earnings Release |
2024-03-25 | H.C. Wainwright Cell Therapy Virtual Conference |
2024-03-07 14:10 | ELRIG Forum |
2024-03-04 | East-West Biopharma Summit |
2024-02-28 12:30 | CAR-TCR Europe Summit |
2024-02-28 07:30 | CAR-TCR Europe Summit - Panel |
2024-01-07 | JPMorgan Healthcare Conference |
2023-11-27 08:05 | Deutsches Eigenkapital Forum |
2023-11-05 | Bio-Europe Conference |
2023-11-04 12:00 | Society for Immunotherapy of Cancer Meeting - Abstract number: 388 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 10,6 7,95 33.74% | 8,75 8,43 3.85% | 10,5 9,40 11.31% | 0,00 | 6,03 5,50 9.71% | 10,6 |
EBITDA Million EUR | Released Forecast Spread | -17,8 -24,0 25.88% | -22,2 -22,0 -0.93% | -6,56 -11,7 43.96% | 0,00 | -14,7 -18,1 18.86% | -11,8 |
EBIT Million EUR | Released Forecast Spread | -20,2 -27,0 25.33% | -28,7 -23,3 -22.93% | -9,99 -11,7 14.73% | 0,00 | -16,1 -18,8 13.87% | -11,8 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -19,9 -26,3 24.27% | -28,4 -24,6 -15.63% | -10,3 -14,0 26.55% | 0,00 | -16,6 -19,4 14.25% | -11,7 |
Net income Million EUR | Released Forecast Spread | -20,0 -26,3 24.1% | -28,9 -22,8 -26.48% | -9,98 -14,0 28.69% | -8,33 | -16,2 -18,9 14.18% | -11,7 |
EPS EUR | Released Forecast Spread | -0,81 -1,09 25.69% | -1,18 -0,93 -27.57% | -0,41 -0,48 14.58% | -0,34 | -0,66 -0,79 16.46% | -0,37 |
Announcement Date | 26/03/20 | 25/03/21 | 23/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 1,55 0,00 - | 3,06 0,00 - | 2,97 2,74 8.39% | 4,15 | 6,85 |
EBITDA Million EUR | Released Forecast Spread | -6,48 | -6,62 -12,7 47.8% | -8,07 -11,4 29.25% | -7,20 | -4,60 |
EBIT Million EUR | Released Forecast Spread | -4,12 | -7,37 | -8,78 -11,4 23.01% | -7,20 | -4,60 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,26 -6,02 29.34% | -7,70 -11,6 33.55% | -8,89 -11,7 23.99% | -7,10 | -4,50 |
Net income Million EUR | Released Forecast Spread | -4,06 -6,02 32.61% | -6,97 -11,6 39.85% | -9,21 -12,5 26.34% | -7,10 | -4,50 |
EPS EUR | Released Forecast Spread | -0,17 -0,74 77% | -0,28 -1,44 80.58% | -0,38 -0,51 25.49% | -0,28 | -0,12 |
Announcement Date | 17/08/23 | 17/08/23 | 28/03/24 | - | - |
Past sector events for MediGene AG
2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- MDG1 Stock
- Stock
- Calendar MediGene AG